ImmunoCellular Therapeutics, Ltd. - IMUC

IMUC Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
IMUC	32.8	0	-5.3	15.9	44.2	-59.5	-33.3	-66.0	-99.9	-100.0
S&P 500	-0.5	-1.3	2.2	3.9	11.1	22.6	33.7	83.9	202.7	34097.7

Compare IMUC with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	IMUC
name	ImmunoCellular Therapeutics, Ltd.
price	0.16
changes percentage	32.7801
change	0.0395
day low	0.1205
day high	0.16
year high	0.39
year low	0.072
market cap	18123360
price avg 50	0.16708
price avg 200	0.15822
exchange	PNK
volume	100
avg volume	2225
open	0.1205
previous close	None
eps	8.89
pe	0.02
earnings announcement	None
shares outstanding	113271000
timestamp	2025-01-29 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 41.7%

Overall Quarterly Financial Health: 50.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000822411
revenue	0	0	NaN
gross profit	0	0	NaN
gross profit ratio	0	0	NaN
research and development expenses	580910	1225592	-52.60
operating expenses	1816320	2885309	-37.05
interest income	0	0	NaN
interest expense	550726	0	NaN
ebitda	-1062010	-2435507	56.39
ebitdaratio	0	0	NaN
operating income	-1816320	-2885310	37.05
operating income ratio	0	0	NaN
net income	-1612737	-2646904	39.07
net income ratio	0	0	NaN
eps	-0.01	-0.02	39.32

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 1 million in 2023 from 1 million in 2022 representing a change of -52.6%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 2 million in 2023 from 3 million in 2022 representing a change of -37.05%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Earnings per Share (EPS): EPS increased to -0.01 in 2023 from -0.01 in 2022 representing a change of 39.32%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -1 million in 2023 from -2 million in 2022 representing a change of 56.39%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to -2 million in 2023 from -3 million in 2022 representing a change of 37.05%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -2 million in 2023 from -3 million in 2022 representing a change of 39.07%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2023Q3	2023Q2	Q/Q change %
0000822411
revenue	0	0	NaN
gross profit	0	0	NaN
gross profit ratio	0	0	NaN
research and development expenses	0	0	NaN
operating expenses	0	0	NaN
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	0	0	NaN
ebitdaratio	0	0	NaN
operating income	0	0	NaN
operating income ratio	0	0	NaN
net income	0	0	NaN
net income ratio	0	0	NaN
eps	0	0	NaN

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000822411
total assets	409422	768803	-46.75
total liabilities	6101905	4957404	23.09
total equity	-5692483	-4188601	-35.90
cash and cash equivalents	278260	613244	-54.62
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	409422	768803	-46.75
total non current assets	0	0	NaN
total current liabilities	5654856	3667467	54.19
total non current liabilities	447049	1289937	-65.34
common stock	11327	11327	0.00
retained earnings	-10861635	-9248898	-17.44
total debt	4735282	3467167	36.57

Overall Score of Annual Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 0 million in 2023 from 1 million in 2022 representing a change of -46.75%. Suggesting a decrease in asset holdings.

  Total Liabilities: Total Liabilities increased to 6 million in 2023 from 5 million in 2022 representing a change of 23.09%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to -6 million in 2023 from -4 million in 2022 representing a change of -35.9%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 0 million in 2023 from 1 million in 2022 representing a change of -54.62%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 0 million in 2023 from 1 million in 2022 representing a change of -46.75%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 6 million in 2023 from 4 million in 2022 representing a change of 54.19%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to -11 million in 2023 from -9 million in 2022 representing a change of -17.44%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 5 million in 2023 from 3 million in 2022 representing a change of 36.57%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2023Q3	2023Q2	Q/Q change %
0000822411
total assets	0	0	NaN
total liabilities	0	0	NaN
total equity	0	0	NaN
cash and cash equivalents	0	0	NaN
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	0	0	NaN
total non current assets	0	0	NaN
total current liabilities	0	0	NaN
total non current liabilities	0	0	NaN
common stock	0	0	NaN
retained earnings	0	0	NaN
total debt	0	0	NaN

Overall Score of Quarterly Balance Sheet

0.5 out of 1

Detailed Analysis

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000822411
net change in cash	-334984	-873322	61.64
operating cash flow	-1421984	-2623322	45.79
free cash flow	-1421980	-2623322	45.79
capital expenditure	4	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	4	0	NaN
net cash used for investing activites	0	0	NaN
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	1087000	1750000	-37.89
cash at end of period	278260	613244	-54.62
accounts receivables	0	0	NaN
cash at beginning of period	613244	1486566	-58.75

Overall Score of Annual Cashflow Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 0 million in 2023 from -1 million in 2022 representing a change of 61.64%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to -1 million in 2023 from -3 million in 2022 representing a change of 45.79%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to -1 million in 2023 from -3 million in 2022 representing a change of 45.79%. This indicates an increase in cash generated after accounting for capital expenditures.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to 0 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023Q3	2023Q2	Q/Q change %
0000822411
operating cash flow	0	0	NaN
free cash flow	0	0	NaN
capital expenditure	0	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	0	0	NaN
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	0	0	NaN
net change in cash	0	0	NaN
cash at end of period	0	0	NaN
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0	0	NaN
net income per share	-0.01	-0.02	39.07
operating cash flow per share	-0.01	-0.02	45.79
free cash flow per share	-0.01	-0.02	45.79
cash per share	0.0	0.01	-54.62
book value per share	-0.05	-0.04	-35.90
tangible book value per share	-0.05	-0.04	-35.90
shareholders equity per share	-0.05	-0.04	-35.90
interest debt per share	0.05	0.03	52.46
market cap	26278814.23	92848034.59	-71.70
enterprise value	30735836.23	95701957.59	-67.88
pe ratio	-16.29	-35.08	53.55
price to sales ratio	0	0	NaN
pocfratio	-18.48	-35.39	47.79
pfcf ratio	-18.48	-35.39	47.79
pb ratio	-4.62	-22.17	79.17
ptb ratio	-4.62	-22.17	79.17
ev to sales	0	0	NaN
enterprise value over ebitda	-28.94	-39.29	26.35
ev to operating cash flow	-21.61	-36.48	40.75
ev to free cash flow	-21.61	-36.48	40.75
earnings yield	-0.06	-0.03	-115.27
free cash flow yield	-0.05	-0.03	-91.52
debt to equity	-0.83	-0.83	-0.49
debt to assets	11.57	4.51	156.46
net debt to ebitda	-4.2	-1.17	-258.15
current ratio	0.07	0.21	-65.46
interest coverage	-3.3	0	NaN
income quality	0.88	0.99	-11.04
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	-0.0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	0.13	0.14	-9.00
roic	1.85	51.25	-96.39
return on tangible assets	-3.94	-3.44	-14.41
graham net net	-0.05	-0.04	-34.06
working capital	-5245434	-2898664	-80.96
tangible asset value	-5692483	-4188601	-35.90
net current asset value	-5692483	-4188601	-35.90
invested capital	-5245434	-2898664	-80.96
average receivables	0	0	NaN
average payables	0	0	NaN
average inventory	0	0	NaN
days sales outstanding	0	0	NaN
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	0	0	NaN
payables turnover	0	0	NaN
inventory turnover	0	0	NaN
roe	0.28	0.63	-55.17
capex per share	0.0	0	NaN

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.28 on 2023-12-31 from 0.63 on 2022-12-31, representing a change of -55.17%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to -16.29 on 2023-12-31 from -35.08 on 2022-12-31, representing a change of 53.55%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to -0.83 on 2023-12-31 from -0.83 on 2022-12-31, representing a change of -0.49%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio decreased to 0.07 on 2023-12-31 from 0.21 on 2022-12-31, representing a change of -65.46%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Quarterly Financial Ratios

	2023-09-30 Q3	2023-06-30 Q2	Q/Q change %
IMUC
calendar year	2023	2023	NaN
revenue per share	0	0	NaN
net income per share	0	0	NaN
operating cash flow per share	0	0	NaN
free cash flow per share	0	0	NaN
cash per share	0	0	NaN
book value per share	0	0	NaN
tangible book value per share	0	0	NaN
shareholders equity per share	0	0	NaN
interest debt per share	0	0	NaN
market cap	0	0	NaN
enterprise value	0	0	NaN
pe ratio	0	0	NaN
price to sales ratio	0	0	NaN
pocfratio	0	0	NaN
pfcf ratio	0	0	NaN
pb ratio	0	0	NaN
ptb ratio	0	0	NaN
ev to sales	0	0	NaN
enterprise value over ebitda	0	0	NaN
ev to operating cash flow	0	0	NaN
ev to free cash flow	0	0	NaN
earnings yield	None	None	NaN
free cash flow yield	0	0	NaN
debt to equity	0	0	NaN
debt to assets	0	0	NaN
net debt to ebitda	0	0	NaN
current ratio	0	0	NaN
interest coverage	0	0	NaN
income quality	0	0	NaN
dividend yield	None	None	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	0	0	NaN
roic	0	0	NaN
return on tangible assets	0	0	NaN
graham net net	0	0	NaN
working capital	0	0	NaN
tangible asset value	0	0	NaN
net current asset value	0	0	NaN
invested capital	0	0	NaN
average receivables	0	0	NaN
average payables	0	0	NaN
average inventory	0	0	NaN
days sales outstanding	0	0	NaN
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	0	0	NaN
payables turnover	0	0	NaN
inventory turnover	0	0	NaN
roe	0	0	NaN
capex per share	0	0	NaN

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is -0.04 which is lower than current price 0.16, indicates the company may be overvalued.